Alilusem

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAlilusem
Drug Alias Name阿利卢森Alilusemum阿利鲁生M-17055MD-31
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsEdema
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMochda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsEdema

Other Information

ATC CodeN/A
Related LinksKEGG